-
Bortezomib in multiple myeloma. Best Practice & Research Mateos MV, San Miguel JF Clinical Haematology 20(4):701-15 FI: 3.134 (Q2) Extended follow¿up of a phase 3 trial in relapsed multiple myeloma: final time to event results of the APEX trial Richardson PG, Sonneveld P, Schuster M, Irwin D, Stadtmauer E, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San Miguel JF, Blade J, Boccadoro M, Cavenagh J, Alsina M, Rajkumar SV, Lacy M, Jakubowiak A, Dalton W, Boral A, Esseltine DL, Schenkein D, Anderson KC Hematology 110(10):3557-60 FI: 1.333 (Q4) Functional class switch recombination may occur ¿in vivo¿ in Waldenstrom macroglobulinemia Martín-Jiménez P, García-Sanz R, Sarasquete ME, Ocio E, Pérez JJ, González M, San Miguel JF British Journal of Haematology 136(1):114-6 FI: 4.597 (Q1) GEM/PETHEMA Spanish Group. Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis Gutiérrez NC, Castellanos MV, Martín ML, Mateos MV, Hernández JM, Fernández M, Carrera D, Rosiñol L, Ribera JM, Ojanguren JM, Palomera L, Gardella S, Escoda L, Hernández-Boluda JC, Bello JL, de la Rubia J, Lahuerta JJ, San Miguel JF Leukemia 21(1):143-50 FI: 8.296 (Q1) Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals Gutiérrez NC, Ocio EM, de Las Rivas J, Maiso P, Delgado M, Fermiñán E, Arcos MJ, Sánchez ML, Hernández JM, San Miguel JF Leukemia 21(3):541-9 FI: 8.296 (Q1) Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma González D, van der Burg M, García-Sanz R, Fenton JA, Langerak AW, González M, van Dongen JJ, San Miguel JF, Morgan GJ Blood 110(9):3112-21 FI: 10.555 (Q1) JS-K, a GST-activated nitric oxide generator, induces DNA double strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells Kiziltepe T, Hideshima T, Ishitsuka K, Ocio EM, Raje N, Catley L, Li CQ, Trudel LJ, Yasui H, Vallet S, Kutok JL, Chauhan D, Mitsiades CS, Saavedra JE, Wogan GN, Keefer LK, Shami PJ, Anderson KC 110(2):709-18 FI: 10.555 (Q1) Mieloma múltiple García-Sanz R, Mateos MV, San Miguel JF Medicina Clínica 129(3):104-15 FI: 1.231 (Q3) Molecular biology of myeloma Gutiérrez NC, García-Sanz R, San Miguel JF Clinical & Translational Oncology 9(10):618-24 FI: 1.146 (Q4) Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenstrom¿s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance Martín-Jiménez P, García-Sanz R, Balanzategui A, Alcoceba M, Ocio E, Sánchez ML, González M, San Miguel JF Haematologica 92(5):635-42 FI: 6.416 (Q1)
|
